The pet blood pressure monitoring devices market is estimated to be valued at USD 150.0 million in 2025 and is projected to reach USD 284.2 million by 2035, registering a compound annual growth rate (CAGR) of 6.6% over the forecast period.
Growth is supported as routine screening for feline hypertension and peri anesthesia surveillance in canine procedures is embedded across general practice and specialty referral centers. Uptake is expected to favor oscillometric hand held units for ease of use, while Doppler systems are retained where systolic accuracy on small patients is prioritized. Procurement decisions are driven by cuff range coverage, calibration support, contamination control, and reliable repeatability that limits retakes. Integration with basic medical records, audible feedback, and clear user interfaces is preferred to streamline clinic workflow. In this segment, accurate, repeatable readings are treated as non negotiable, which places measurement stability ahead of cosmetic features.
Over 2030 to 2035, the market is expected to advance from USD 206.5 million to USD 284.2 million, following 220.1, 234.6, 250.1, 266.6, and 284.2 and preserving a 6.6 percent CAGR across the full window. Late period momentum is set to come from replacement cycles, broader placement in general practice rooms, and at home monitoring for chronic kidney and endocrine cases where longitudinal baselines are required. Multi parameter vital signs stations are specified by larger hospitals, while compact devices satisfy mobile veterinarians and tele triage workflows that need quick snapshots without complex setup. Purchase criteria should emphasize validated cuffs across sizes, robust service through veterinary distributors, stable battery performance, and hygienic enclosures that tolerate frequent cleaning. As installed bases expand, training time, maintenance simplicity, and dependable after sales support are expected to outweigh minor feature differences.
| Metric | Value |
|---|---|
| Pet Blood Pressure Monitoring Devices Market Estimated Value in (2025 E) | USD 150.0 million |
| Pet Blood Pressure Monitoring Devices Market Forecast Value in (2035 F) | USD 284.2 million |
| Forecast CAGR (2025 to 2035) | 6.6% |
The pet blood pressure monitoring devices market represents a small but distinct proportion across its parent industries, with differentiated shares depending on the scope of each segment. Within the veterinary healthcare devices market, the segment contributes close to 3%, driven by the specialized nature of diagnostic applications. In the pet monitoring and diagnostics equipment market, it holds about 5%, since other categories such as imaging and biochemical diagnostics capture larger volumes. In the animal health monitoring devices market, its contribution stands at around 4%, showing gradual growth due to the rising clinical focus on cardiovascular health in pets. When analyzed within the small animal veterinary equipment market, the segment maintains nearly 2%, as surgical instruments and general diagnostic kits dominate the category.
Within the pet wearable health monitoring devices market, the share reaches approximately 6%, as connected health and remote monitoring technologies provide more opportunities for integration of blood pressure modules. These variations highlight how the segment maintains a modest role in broader veterinary technology ecosystems, yet its shares are expanding in spaces where preventive and continuous monitoring are gaining importance. The relatively higher contribution in the wearable health monitoring space compared to general veterinary equipment underlines the shift toward pet wellness tracking, while the lower shares in large equipment markets reflect its niche status. Overall, pet blood pressure monitoring devices remain a minor contributor across parent markets, yet their share demonstrates steady upward momentum as hypertension screening and companion animal diagnostics gain clinical acceptance.
The market is experiencing consistent growth, supported by increasing awareness among pet owners and veterinary professionals regarding the importance of cardiovascular health monitoring in companion animals. Advancements in veterinary diagnostics, combined with the rise in chronic conditions such as hypertension and kidney disorders among pets, have created a strong demand for accurate and non-invasive monitoring solutions.
The integration of digital technologies, including wireless connectivity and data storage, is enhancing diagnostic accuracy and enabling continuous monitoring capabilities. Veterinary clinics and specialty hospitals are expanding their adoption of sophisticated blood pressure monitoring devices to support preventive healthcare and early disease detection.
Additionally, rising pet ownership, higher expenditure on veterinary care, and an emphasis on extending the quality of life for pets are further driving market adoption The growing availability of portable and user-friendly devices is encouraging wider use in both clinical and home settings, positioning the market for steady expansion in the coming years.
The pet blood pressure monitoring devices market is segmented by animal type, product, monitoring technique, modality, end use, and geographic regions. By animal type, pet blood pressure monitoring devices market is divided into dogs, cats, and other animal types. In terms of product, pet blood pressure monitoring devices market is classified into devices and consumables. Based on monitoring technique, pet blood pressure monitoring devices market is segmented into indirect arterial blood pressure (IABP) and direct arterial blood pressure (DABP). By modality, pet blood pressure monitoring devices market is segmented into portable and benchtop. By end use, pet blood pressure monitoring devices market is segmented into veterinary hospital, veterinary clinics, and other end use. Regionally, the pet blood pressure monitoring devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The dogs segment is projected to account for 52% of the market revenue share in 2025, making it the leading animal type. Growth in this segment has been driven by the higher prevalence of hypertension-related conditions in dogs, especially as they age or suffer from chronic illnesses.
Increased veterinary visits for routine check-ups have enabled earlier detection of cardiovascular issues, prompting the adoption of blood pressure monitoring as part of standard canine health assessments. Pet owners have demonstrated greater willingness to invest in advanced diagnostic tools for dogs, given their role as valued family companions.
The availability of non-invasive, easy-to-use devices has encouraged veterinarians to recommend regular monitoring for at-risk canine populations In addition, ongoing education initiatives by veterinary associations have highlighted the importance of blood pressure screening in dogs, reinforcing demand for specialized monitoring equipment within this segment.
The devices segment is expected to hold 73.30% of the market revenue share in 2025, positioning it as the dominant product category. This segment’s leadership is supported by the widespread use of dedicated blood pressure monitors in veterinary practices and research settings. Devices offer greater accuracy, consistent readings, and advanced features such as automated inflation and real-time data display, which are critical for effective diagnosis.
Technological innovations have improved portability and ease of operation, enabling broader use in clinics and mobile veterinary services. The shift towards preventive healthcare in pets has increased demand for dedicated devices capable of monitoring vital signs over time.
Veterinary professionals value the reliability of these devices for both routine health checks and critical care situations As the market continues to evolve, the integration of devices with digital record-keeping systems and telemedicine platforms is expected to further strengthen their role in veterinary diagnostics.
The indirect arterial blood pressure (IABP) monitoring technique segment is anticipated to secure 63.90% of the market revenue share in 2025, making it the leading monitoring technique. This method has been favored for its non-invasive nature, which minimizes stress on animals during measurement while maintaining reliable accuracy.
IABP techniques, such as oscillometric and Doppler-based systems, have been widely adopted in veterinary settings due to their ease of use and suitability for different animal sizes. The segment’s dominance has also been reinforced by its cost-effectiveness compared to invasive methods, making it accessible for routine use in clinics and wellness programs.
Increased awareness of the importance of monitoring blood pressure in managing chronic diseases has driven veterinarians to rely on IABP as a standard practice With ongoing improvements in sensor sensitivity and data interpretation, IABP monitoring is expected to remain a preferred technique for both clinical diagnostics and long-term patient management.
The pet blood pressure monitoring devices market is gaining traction as awareness of cardiovascular and renal diseases in companion animals grows. Opportunities are strengthening in specialized veterinary practices and emerging regions, while trends highlight digital integration, portability, and user-friendly operation. High device costs, accuracy limitations, and maintenance requirements remain key challenges. In my opinion, the competitive edge will belong to manufacturers delivering affordable, reliable, and digitally enabled solutions, enabling wider adoption across veterinary clinics and home-care settings, ultimately advancing preventive healthcare for pets worldwide.
Demand for pet blood pressure monitoring devices has been stimulated by rising awareness among veterinarians and pet owners regarding cardiovascular conditions in companion animals. Early diagnosis of hypertension is crucial in managing chronic kidney disease, cardiac disorders, and age-related complications in cats and dogs. The increased adoption of advanced veterinary practices in clinics and hospitals has strengthened reliance on accurate diagnostic devices. In my opinion, demand will continue to rise as preventive care becomes a priority, pushing more veterinary centers to integrate blood pressure monitoring into routine examinations and treatment protocols.
Opportunities are emerging within specialized veterinary facilities focusing on cardiology and nephrology. These centers are driving the uptake of non-invasive monitoring devices designed to provide reliable measurements without causing stress to pets. Portable and handheld units are gaining popularity among home-visit veterinarians and mobile clinics, offering convenience and broader outreach. Growth opportunities are also evident in emerging markets where veterinary infrastructure is developing at a fast pace. I believe manufacturers that design affordable, user-friendly, and pet-specific monitoring solutions will secure a competitive advantage by capturing these niche yet high-value opportunities in veterinary healthcare.
Trends in the pet blood pressure monitoring devices market highlight the shift toward digital interfaces, portability, and compatibility with veterinary management software. Devices are being designed with improved accuracy, ease of use, and stress-free operation, addressing long-standing challenges in monitoring pets. Wireless connectivity is being explored for seamless data sharing between veterinarians and pet owners. In my opinion, this shift indicates that product innovation will not just revolve around accuracy but also user experience, making digital integration and convenience the central themes driving market differentiation and long-term adoption across veterinary practices.
Challenges persist regarding device accuracy and affordability. Pets present unique physiological and behavioral challenges, making consistent readings difficult, especially in anxious or uncooperative animals. High device costs limit adoption among smaller veterinary clinics and individual practitioners, creating disparities in access to advanced diagnostics. Maintenance and calibration issues also add to operational burdens. In my assessment, overcoming these hurdles requires manufacturers to refine sensor technologies, offer flexible pricing models, and provide training for veterinarians. Without such measures, widespread adoption of pet blood pressure monitoring devices may remain restricted to larger hospitals and high-income regions.
| Country | CAGR |
|---|---|
| China | 8.9% |
| India | 8.3% |
| Germany | 7.6% |
| France | 6.9% |
| UK | 6.3% |
| USA | 5.6% |
| Brazil | 5.0% |
The global pet blood pressure monitoring devices market is projected to grow at a CAGR of 6.6% from 2025 to 2035. China leads with a growth rate of 8.9%, followed by India at 8.3%, and Germany at 7.6%. The United Kingdom records a growth rate of 6.3%, while the United States shows the slowest growth at 5.6%. Growth in emerging markets is fueled by increasing pet ownership, rising awareness of animal health, and expanding veterinary healthcare infrastructure. Mature markets such as the UK and USA witness steady growth due to technological adoption, preventive pet healthcare trends, and growing investment in veterinary diagnostics. The analysis spans over 40 countries, highlighting leading markets.
The pet blood pressure monitoring devices market in China is projected to grow at a CAGR of 8.9%. Increasing pet adoption and growing awareness of animal health monitoring are key factors driving demand. Veterinary clinics and pet hospitals are increasingly adopting digital blood pressure monitoring devices for routine check-ups, particularly for cats and dogs with chronic conditions. Rising disposable income and willingness to invest in pet healthcare further support market expansion. Manufacturers are also introducing technologically advanced, easy-to-use, and portable devices, accelerating adoption across urban and semi-urban regions.
The pet blood pressure monitoring devices market in India is expected to grow at a CAGR of 8.3%. Growing urban pet population, rising awareness of preventive pet healthcare, and increasing veterinary infrastructure contribute to market expansion. Adoption of digital monitoring devices in clinics and hospitals ensures accurate and efficient health assessment for pets with hypertension and other cardiovascular concerns. Rising middle-class income and willingness to spend on pet wellbeing also drive demand. Initiatives by veterinary associations promoting regular health check-ups and adoption of modern diagnostic tools further support growth in India.
The pet blood pressure monitoring devices market in Germany is projected to grow at a CAGR of 7.6%. High adoption of veterinary diagnostic technologies and advanced healthcare practices in pet care are key drivers. Awareness regarding chronic cardiovascular conditions in pets encourages owners to seek regular monitoring. Veterinary clinics increasingly rely on automated and digital monitoring devices for precision and ease of use. Growth is further supported by pet insurance schemes, regulatory standards, and rising expenditure on preventive healthcare. The trend of specialized pet hospitals and clinics ensures a consistent demand for accurate blood pressure monitoring devices across Germany.
The pet blood pressure monitoring devices market in the United Kingdom is expected to grow at a CAGR of 6.3%. Rising pet ownership, increasing focus on preventive veterinary care, and adoption of digital health monitoring devices fuel market growth. Veterinary clinics and hospitals are integrating advanced monitoring tools to assess hypertension and cardiovascular health in pets more accurately. Increasing consumer spending on pets, technological innovations in compact and user-friendly devices, and awareness campaigns by veterinary associations provide opportunities for manufacturers and service providers. The UK market benefits from high standards of animal healthcare and early adoption of diagnostic devices.
The pet blood pressure monitoring devices market in the United States is projected to grow at a CAGR of 5.6%. The market is driven by rising pet ownership, increasing awareness of hypertension and cardiovascular issues in pets, and adoption of advanced diagnostic devices by veterinary clinics. Growing demand for preventive healthcare and the availability of portable, easy-to-use monitoring equipment contribute to steady growth. Pet insurance coverage and willingness to invest in pet health services also support adoption. While growth is moderate compared to emerging markets, the USA market remains a key hub for technological innovation, high-quality devices, and standardized veterinary care practices.
A clear hierarchy has been seen in the pet blood pressure monitoring device market, where leadership has been claimed by a small set of specialized brands. SunTech has been commanding attention through its brand trust and veterinary clinic focus, where oscillometric and Doppler-based systems have been regarded as reliable for routine blood pressure readings. Midmark Corporation has been recognized for its clinic-grade platforms that integrate multiple vital signs, where blood pressure measurement has been treated as an essential diagnostic supplement. VetLAND has been carving a presence via dedicated veterinary monitors, where portability and ease of use have been elevated in training and practice settings. Mindray Animal Medical Technology has been expanding influence by supplying veterinary hospitals with equipment suites, where blood pressure modules have been integrated into broader monitoring systems. petMAP has been gaining ground in point-of-care applications, where compact design and veterinary-oriented workflows have been prioritized. A notable portion of market share has been captured by these firms collectively, where emphasis has been placed on oscillometric accuracy, veterinary-specific usability, and dependable results.
Credibility has been reinforced through targeted distribution networks and product performance metrics, where many practices have evaluated diagnostic focus and consistency across species. Distinctive approaches have been adopted across these companies, shaping the competitive landscape around product form factors, user interface, and ecosystem alignment. SunTech and Midmark have been recognized as engineering-driven, with devices validated through clinic deployments and long-term veterinary use. VetLAND and petMAP have been treated as practitioner-friendly options, with compact units suited for mobile patients and space-constrained environments. Mindray has been seen as ecosystem-oriented, where monitoring modules have aligned with multi-parameter platforms and veterinary hospital infrastructure. Each provider has been assessed based on reliability, cuff compatibility, and ease of integration into workflows. This competition has been influencing buyer preference, where practices have leaned toward devices that offer consistent readings, intuitive operation, and dependable service support. The marketplace has been shaped by how effectively each brand has elevated blood pressure monitoring as a routine veterinary diagnostic tool, promoting better clinical decision-making, patient comfort, and veterinary care quality.
| Item | Value |
|---|---|
| Quantitative Units | USD 150.0 Million |
| Animal Type | Dogs, Cats, and Other animal types |
| Product | Devices and Consumables |
| Monitoring Technique | Indirect arterial blood pressure (IABP) and Direct arterial blood pressure (DABP) |
| Modality | Portable and Benchtop |
| End Use | Veterinary hospital, Veterinary clinics, and Other end use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | SunTech (Suntech Medica / SunTech), Midmark Corporation, VETLAND, Mindray Animal Medical Technology, petMAP, and Other companies |
| Additional Attributes | Dollar sales by product type (wearable vs tabletop monitors), Dollar sales by species application (canine, feline, others), Trends in veterinary wellness and chronic disease tracking, Use in clinics and home-care monitoring, Growth of non-invasive and digital diagnostic tools, Regional adoption differences across North America, Europe, and Asia-Pacific. |
The global pet blood pressure monitoring devices market is estimated to be valued at USD 150.0 million in 2025.
The market size for the pet blood pressure monitoring devices market is projected to reach USD 284.2 million by 2035.
The pet blood pressure monitoring devices market is expected to grow at a 6.6% CAGR between 2025 and 2035.
The key product types in pet blood pressure monitoring devices market are dogs, cats and other animal types.
In terms of product, devices segment to command 73.3% share in the pet blood pressure monitoring devices market in 2025.
Explore Similar Insights
Pet Blood Pressure Monitoring Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
